Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125567671 | 12556767 | 1 | I | 20160627 | 20160707 | 20160714 | 20160714 | PER | US-ELI_LILLY_AND_COMPANY-US201607003298 | ELI LILLY AND CO | 63.64 | YR | M | Y | 0.00000 | 20160714 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125567671 | 12556767 | 1 | PS | ADCIRCA | TADALAFIL | 1 | Oral | 20 MG, BID | U | U | C495978A | 21368 | 20 | MG | TABLET | BID | |||
| 125567671 | 12556767 | 2 | C | VELETRI | EPOPROSTENOL | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125567671 | 12556767 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125567671 | 12556767 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125567671 | 12556767 | Chills | |
| 125567671 | 12556767 | Cough | |
| 125567671 | 12556767 | Dyspnoea | |
| 125567671 | 12556767 | Heart rate increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125567671 | 12556767 | 1 | 20160627 | 20160627 | 0 | |
| 125567671 | 12556767 | 2 | 201511 | 0 |